IDEAYA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
Provided By PR Newswire
Last update: Aug 5, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 5, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology company committed to advancing the discovery, development, and commercialization of transformative precision medicines to address unmet medical needs in cancer, provided a business update and announced financial results for the second quarter ended June 30, 2025.
Read more at prnewswire.com
